Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

6.25
+0.16002.63%
Post-market: 6.250.00000.00%19:36 EDT
Volume:1.54M
Turnover:9.49M
Market Cap:258.73M
PE:-5.49
High:6.31
Open:6.10
Low:6.00
Close:6.09
52wk High:13.22
52wk Low:4.48
Shares:41.40M
Float Shares:36.26M
Volume Ratio:2.46
T/O Rate:4.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1385
EPS(LYR):-0.9533
ROE:-17.35%
ROA:-10.41%
PB:0.98
PE(LYR):-6.56

Loading ...

RxSight’s Long-Term Lens Study: What Ongoing Results Could Mean For RXST Investors

TIPRANKS
·
Aug 13

Eye Care Company Alcon Raises Margin Outlook, Shares Jump

Reuters
·
Aug 11

Alcon Shares Seen Rising After Outlook Hike

Reuters
·
Aug 11

Rxsight’s Earnings Call: Alcon Deal vs. Headwinds

TIPRANKS
·
Aug 09

Analysts Are Neutral on Top Healthcare Stocks: Annexon Biosciences (ANNX), RxSight (RXST)

TIPRANKS
·
Aug 08

J.P. Morgan Sticks to Their Sell Rating for RxSight (RXST)

TIPRANKS
·
Aug 07

RxSight is Maintained at Neutral by UBS

Dow Jones
·
Aug 07

Tarsus Pharmaceuticals Q2 Sales Beat Estimates, Lifts 2026 Xdemvy Sales Outlook

Reuters
·
Aug 06

Germany's Carl Zeiss Meditec 9-Month Revenue Falls 2.9%

Reuters
·
Aug 06

RxSight, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

RxSight Q2 2026 Earnings: Alcon Revenue Offsets a 19% Product Sales Decline

TradingKey
·
Aug 06

RxSight Q2 FY26 Net Loss Widens 2.6% to $12.1 Million; Revenue Rises 0.3% to $33.7 Million

Reuters
·
Aug 06

RxSight Q2 Adjusted Loss Beats Estimates; Withdraws 2026 Guidance

Reuters
·
Aug 06

Rxsight Inc Q2 Operating Expenses USD 39.7 Million

Reuters
·
Aug 06

Rxsight Inc Q2 EPS USD -0.29

THOMSON REUTERS
·
Aug 06

RxSight, Inc. Expected to Post a Loss of 33 Cents a Share - Earnings Preview

Reuters
·
Aug 04

RxSight Coverage Assumed by UBS at Neutral

Dow Jones
·
Jul 29

UBS Adjusts Price Target on RxSight to $5.50 From $9, Maintains Neutral Rating

MT Newswires Live
·
Jul 28

Rxsight Grants New CEO Aziz Mottiwala Stock Options for 571,286 Shares at $5.19 Each

Reuters
·
Jul 27

Rxsight Reports Inducement Grants as Permitted by the NASDAQ Listing Rules

THOMSON REUTERS
·
Jul 27